Vaccine Against Atherosclerosis in Patients With Overweight Problems or Obesity

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 300 participants.

Also called NCT03042741

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 300 participants (planned count) (from the registry)
Sponsor
Immunitor LLC (from the registry)
Registry
  • NCT NCT03042741
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Mongolia (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT03042741. Randomized; triple masking; primary purpose treatment. Start 2017-02-01 (actual); primary completion 2019-12-18 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Vaccine Against Atherosclerosis in Patients With Overweight Problems or Obesity
Acronym
V6
Condition
Atherosclerosis
Intervention (Biological)
atherosclerosis vaccine
Intervention (Biological)
Placebo pills
Lead sponsor
Immunitor LLC (class: industry)
Collaborator
Federal State Budget Institution Research Center for Obstetrics, Gynecology and Perinatology Ministry of Healthcare (class: other government)

Record details

Record id
cardio:ct-nct03042741
Content hash
c4e3a016037edde7b73d5e3d2d2389e08484f64533c1cfbaa3d4bc2a6de07cca